An Exploratory Clinical Trial to Evaluate and Compare Safety and Pharmacokinetic Characteristics After Administration of the DWJ1439, DWJ1464, DWC202108 or DWC202109 in Healthy Adult Volunteers
Latest Information Update: 15 May 2024
At a glance
- Drugs DWJ 1439 (Primary) ; Ursodeoxycholic acid (Primary)
- Indications Unspecified
- Focus Pharmacokinetics
- Sponsors Daewoong Pharmaceutical
Most Recent Events
- 03 May 2023 New trial record